Loading…

Advance Your Practice with Latest CME Enroll now and gain certified credits

Ask Me About HIV & PrEP:

Education for Clinicians in Asia 2.0

This educational activity is supported by an independent educational grant from Gilead Sciences, Inc.

Expert commentary from Tanyaporn Wansom and Ken Sujin Ho on HIV trends, PrEP, and rapid ART initiation and treatment selection.

Pre-activity assessment

Respond to the questions below to unlock the next part of the activity, covering HIV incidence trends, PrEP benefits and eligibility, and rapid ART initiation and treatment selection.

1. I counsel my patients in high-risk groups about HIV testing recommendations.

2. I discuss PrEP with individuals who may be at elevated risk of acquiring HIV.

3. A patient asks about starting PrEP. Which of the below would prevent initiation of PrEP at this time?

4. A patient is newly diagnosed with HIV and is ready to begin ART quickly. This patient has never used PrEP before. Results of HIV genotype, hepatitis B serology, and HLA-B*5701 testing are not yet available. Which of the following options includes appropriate regimens for rapid initiation of ART?

Answer every question to continue.

Funding

This educational activity is supported by an independent educational grant from Gilead Sciences, Inc.

Disclaimer of unlabelled use

Ask Me About HIV & PrEP: Education for Clinicians in Asia 2.0 [Thailand] may include presentations on drugs or devices, or use of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice.

DKBmed is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations on off-label uses, does not imply an endorsement by DKBmed of the uses, products, or techniques presented.

Statement of responsibility

DKBmed takes responsibility for the content, quality, and scientific integrity of this activity.

Copyright

All rights reserved – DKBmed. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

Disclaimer statement

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

Americans with Disabilities Act

DKBmed fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.